Skip to main content
MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED logo

MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED — Investor Relations & Filings

Ticker · MVP ISIN · AU000000MVP2 LEI · 9845007EAECAOD1U4493 ASX Manufacturing
Filings indexed 908 across all filing types
Latest filing 2014-10-27 Regulatory Filings
Country AU Australia
Listing ASX MVP

About MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED

https://medicaldev.com

Medical Developments International Limited specializes in the development and distribution of emergency pain relief and respiratory products. The company's flagship product is Penthrox, a handheld, self-administered inhaler providing rapid-onset, non-opioid analgesia using methoxyflurane. Penthrox is utilized globally by emergency medical services, hospitals, and for procedural pain in various clinical settings. Additionally, the company manufactures a range of respiratory medical devices, including anti-static spacers and asthma management tools designed to optimize medication delivery. The organization focuses on providing portable, effective solutions for acute pain management and respiratory care, catering to healthcare professionals and patients in emergency, surgical, and primary care environments.

Recent filings

Filing Released Lang Actions
2014 AGM Presentation 10 pages 298.8KB
Regulatory Filings Classification · 85% confidence The document is a business update discussing future prospects, regulatory submissions, sales growth, and product development for the fiscal year 2014 and 2015. It includes trading updates with percentage increases in sales and EBIT but does not contain detailed financial statements or comprehensive financial analysis. The document length is 3306 characters, which is relatively short and reads more like a business or trading update rather than a full financial report. There is no indication that this is an official annual or interim report, audit report, or earnings release. It also does not fit categories like investor presentation or regulatory filing. Given the content and length, the document best fits the category of a Regulatory Filings (RNS) as a general business update that does not neatly fit into other specific categories.
2014-10-27 English
Results of Meeting 2 pages 142.8KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is dated 28 October 2014 and is addressed to the Australian Securities Exchange. It reports the results of the 2014 Annual General Meeting (AGM) of Medical Developments International Ltd. The content includes detailed voting results for resolutions such as the Remuneration Report and the election/re-election of directors. The document explicitly states it is the 'Results of 2014 ANNUAL GENERAL MEETING' and provides proxy summaries and poll results. The document length is short (1989 characters) and focuses solely on voting outcomes rather than the full AGM materials or presentations. Therefore, this document is best classified as a Declaration of Voting Results & Voting Rights Announcements (DVA).
2014-10-27 English
Annual Report to Shareholders 70 pages 3.2MB
Annual Report Classification · 100% confidence The document is titled 'Annual Report 2014' and contains detailed sections typical of an annual report, including Chairman’s and CEO’s report, summary of key achievements, review of operations, product portfolio, board of directors, full-year report, financials, and stock exchange information. It includes comprehensive financial performance data, operational reviews, regulatory approvals, and business outlook for the fiscal year ended 30 June 2014. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. There is no indication that this is merely an announcement of the report or a certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2014
2014-09-25 English
Notice of Annual General Meeting 9 pages 474.1KB
AGM Information Classification · 100% confidence The document is titled 'NOTICE OF ELEVENTH ANNUAL GENERAL MEETING' and includes details about the date, location, agenda items such as receiving financial statements, adoption of the remuneration report, and election of directors. It also contains procedural information about voting, proxies, and shareholder rights. The content is consistent with a notice sent to shareholders to inform them about the upcoming AGM and the matters to be discussed and voted upon. There is no actual financial data or reports included, only references to them and instructions for the meeting. Therefore, this document is a notice for the Annual General Meeting, not the Annual Report or any other report itself.
2014-09-25 English
Proxy Form 2 pages 315.1KB
AGM Information Classification · 95% confidence The document is a proxy form for an Annual General Meeting (AGM) of Medical Developments International Limited. It includes instructions on how to vote, appoint proxies, and details about the meeting date and location. It does not contain financial statements, management discussion, or detailed report content. It is a form used to facilitate voting at the AGM, not the AGM presentation materials themselves. Therefore, it fits the category of AGM Information (AGM-R), which includes presentations and materials shared during the AGM, including proxy forms and voting instructions.
2014-09-25 English
Major European Deal for Penthrox 2 pages 232.4KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 11 September 2014 about a major European distribution, license, and supply agreement for the product Penthrox. It discusses the terms of the agreement, upfront payments, and market expansion plans. There are no financial statements, quarterly or annual results, or detailed financial data presented. The document is a corporate announcement about a significant commercial deal, not a financial report or regulatory filing. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Capital/Financing Update. It is a business update related to a commercial agreement, which aligns best with a Regulatory Filing (RNS) as a general announcement that does not fit other specific categories.
2014-09-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.